4528 · ONO PHARMACEUTICAL CO., LTD. · Financials
Income-statement, balance-sheet and cash-flow figures read from the company's own published financial reports.
Revenue
515.79B
FY2026
Net Income
69.77B
FY2026
Gross Margin
72.52%
FY2026
Operating Margin
17.88%
FY2026
Operating Cash Flow
136.82B
FY2026
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | FY2026 |
|---|---|
| JPY | 515.79B |
| JPY | 141.72B |
| JPY | 374.07B |
| JPY | 92.24B |
| JPY | 92.65B |
| JPY | 22.74B |
| JPY | 69.77B |
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
Debt Profile
No verified debt profile is available yet. This does not establish that the company has no debt or covenants.